Pascal Prigent
Chief Executive Officer en GENFIT .
Fortuna: 74 698 $ al 31/03/2024
Perfil
Pascal Prigent is currently the Chief Executive Officer at Genfit SA. Previously, he held the position of Vice President & General Manager at GlaxoSmithkline SRL from 2011 to 2014, and Vice President-Marketing at GlaxoSmithKline LLC from 2014 to 2017.
Mr. Prigent obtained an MBA from INSEAD in 1995 and an undergraduate degree from NEOMA Business School in 1989.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
GENFIT SA
0.04% | 01/04/2023 | 20 708 ( 0.04% ) | 74 698 $ | 31/03/2024 |
Cargos activos de Pascal Prigent
Empresas | Cargo | Inicio |
---|---|---|
GENFIT | Chief Executive Officer | 16/09/2019 |
Antiguos cargos conocidos de Pascal Prigent.
Empresas | Cargo | Fin |
---|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Sales & Marketing | 01/11/2017 |
GlaxoSmithkline SRL
GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Corporate Officer/Principal | 01/03/2014 |
Formación de Pascal Prigent.
INSEAD | Masters Business Admin |
NEOMA Business School | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GENFIT | Health Technology |
Empresas privadas | 2 |
---|---|
GlaxoSmithkline SRL
GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian subsidiary company that operates within the pharmaceutical industry. As a part of the larger GSK Plc, GlaxoSmithkline benefits from the resources and expertise of its parent company. It is involved in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medicines, vaccines, and consumer healthcare products. With a strong focus on innovation and improving global health, GlaxoSmithkline plays a significant role in providing healthcare solutions to people around the world. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Pascal Prigent